Have a personal or library account? Click to login
HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions Cover

HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions

Annals of Global Health
Volume 85 (2019): Issue 1
By: Minodora Bianca Ilisiu,  Dana Hashim,  Trude Andreassen,  Nathalie C. Støer,  Florian Nicula and  Elisabete Weiderpass  
Open Access
|Jun 2019

References

  1. 1Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018 Nov; 68(6): 394–424. DOI: 10.3322/caac.21492
    Back to article
  2. 2Bruni L, Barrionuevo-Rosas L, Albero G, et al. ICO/IARC Information Centre on Papillomavirus and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Romania: Fact Sheet 2018. Summary Report 12 November 2018. [Date Accessed: 29 December 2018].
    Back to article
  3. 3Chiricuta I. http://www.iocn.ro/Centrul-de-prevenire-si-control-al-cancerului/Programul-de-screening-pentru-cancerul-de-col-uterin/Informatii-de-interes-general.html. [Accessed 29 December 2018].
    Back to article
  4. 4Nicula FA, Suteu O, Pais R and Neamtiu L. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009; 45: 2685–2708. DOI: 10.1016/j.ejca.2009.07.025
    Back to article
  5. 5Bruni L, Albero G, Serrano B, et al. WHO/ICO Information Centre on HRHPV and Cervical Cancer (HPV Information Centre): Human Papillomavirus and Related Cancers in World. Summary Report 10 December 2018. Date accessed. February 2, 2019.
    Back to article
  6. 6Romanian Ministry of Health. National Institute of Statistics, Romania. http://www.insse.ro/cms/en/content/official-statistics-romania. Updated April 05, 2017. Acessesed 01 January 2019.
    Back to article
  7. 7Hajioff S and McKee M. The health of the Roma people: A review of the published literature. J Epidemiol Community Health. 2000; 54: 864–869. DOI: 10.1136/jech.54.11.864
    Back to article
  8. 8Andreassen T, Melnic A, Figueiredo R, et al. Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania. International Journal of Public Health. 2018 Jun 1; 63(5): 609–19. DOI: 10.1007/s00038-018-1107-5
    Back to article
  9. 9Andreassen T, Weiderpass E, Nicula F, et al. Controversies about cervical cancer screening: A qualitative study of Roma women’s (non) participation in cervical cancer screening in Romania. Social Science & Medicine. 2017 Jun 1; 183: 48–55. DOI: 10.1016/j.socscimed.2017.04.040
    Back to article
  10. 10Nicula FA, Suteu O, Pais R and Neamtiu L. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009; 45: 2685–2708. DOI: 10.1016/j.ejca.2009.07.025
    Back to article
  11. 11Lorincz A and Anthony J. Advances in HPV detection by hybrid capture. Papillomavirus Rep. 2001; 12: 145–54.
    Back to article
  12. 12Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA. 2002 Apr 24; 287(16): 2114–9. DOI: 10.1001/jama.287.16.2114
    Back to article
  13. 13Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R and Inoue M. Age standardization of rates: A new WHO standard. Geneva: World Health Organization. 2001; 9: 10.
    Back to article
  14. 14Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012 Nov 20; 30: F12–23. DOI: 10.1016/j.vaccine.2012.07.055
    Back to article
  15. 15Bardin A, Vaccarella S, Clifford GM, et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer. 2008; 44(4): 557–64. DOI: 10.1016/j.ejca.2007.12.001
    Back to article
  16. 16Tachezy R, Smahelova J, Kaspirkova J and Salakova M. Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One. 2013; 8(11): e79156. DOI: 10.1371/journal.pone.0079156
    Back to article
  17. 17Ucakar V, Poljak M and Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HRHPV) types in Slovenian women: A cervical cancer screening based study. Vaccine. 2012; 30(2): 116–20. DOI: 10.1016/j.vaccine.2011.10.066
    Back to article
  18. 18Agorastos T, Chatzistamatiou K, Katsamagkas T, et al. Primary screening for cervical cancer based on high-risk human papillomavirus (HRHPV) detection and HRHPV 16 and HRHPV 18 genotyping, in comparison to cytology. PLoS One. 2015; 10(3): e0119755. DOI: 10.1371/journal.pone.0119755
    Back to article
  19. 19Kovachev S, Slavov V and Slavova K. Prevalence of human papillomavirus infection in women in some cities and regions of Bulgaria. J Med Virol. 2013; 85(9): 1577–84. DOI: 10.1002/jmv.23652
    Back to article
  20. 20Uuskula A, Kals M, Kosenkranius L, McNutt LA and DeHovitz JJ. Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infect Dis. 2010; 10: 63. DOI: 10.1186/1471-2334-10-63
    Back to article
  21. 21Kaliterna V, Kaliterna M, Pejkovic L, Hofman ID and Andelinovic S. Prevalence and genotyping of the human papillomavirus in the cervical specimens among women of Southern Croatia (Dalmatia County). Cent Eur J Public Health. 2013; 21(1): 26–9. DOI: 10.21101/cejph.a3814
    Back to article
  22. 22Kliucinskas M, Nadisauskiene RJ and Minkauskiene M. Prevalence and risk factors of HRHPV infection among high-risk rural and urban Lithuanian women. Gynecol Obstet Invest. 2006; 62(3): 173–80. DOI: 10.1159/000093572
    Back to article
  23. 23Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX and de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. Journal of Infectious Diseases. 2010 Dec 15; 202(12): 1789–99. DOI: 10.1086/657321
    Back to article
  24. 24De Vuyst H, Clifford G, Li N and Franceschi S. Age-standardised high-risk (HR) human papillomavirus (HPV) prevalence in 10 European Union countries and Switzerland. Eur J Cancer. 2009; 45: 2632–9. DOI: 10.1016/j.ejca.2009.07.019
    Back to article
  25. 25Nicula F. Programul de Preventie si Control in Patologia Oncologica. Cluj: Editura Medicala Universitara (in Romanian), 2002.
    Back to article
  26. 26Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. Jama. 2001 Jun 20; 285(23): 2995–3002. DOI: 10.1001/jama.285.23.2995
    Back to article
  27. 27Iordanescu E, Iordanescu C and Draghici A. Time and gender influence in sexual behavior of Romanian adolescents. Procedia – Social and Behavioral Sciences. 2015; 187: 757–761. DOI: 10.1016/j.sbspro.2015.03.160
    Back to article
  28. 28Rada C. Sexual behaviour and sexual and reproductive health education: A cross-sectional study in Romania. Reproductive Health. 2014 Dec; 11(1): 48. DOI: 10.1186/1742-4755-11-48
    Back to article
  29. 29Todorova I, Baban A, Alexandrova-Karamanova A and Bradley J. Inequalities in cervical cancer screening in Eastern Europe: perspectives from Bulgaria and Romania. Int J Public Health. 2009; 54(4): 222–32. DOI: 10.1007/s00038-009-8040-6
    Back to article
  30. 30Andreassen T, Melnic A, Figueiredo R, et al. Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania. International Journal of Public Health. 2018; 63(5): 609–619. DOI: 10.1007/s00038-018-1107-5
    Back to article
  31. 31De Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. The Lancet Infectious Diseases. 2007 Jul 1; 7(7): 453–9. DOI: 10.1016/S1473-3099(07)70158-5
    Back to article
  32. 32Kornya L, Cseh I, Deak J, Bak M and Fulop V. The diagnostics and prevalence of genital human papillomavirus (HPV) infection in Hungary. Eur J Obstet Gynecol Reprod Biol. 2002; 100(2): 231–6. DOI: 10.1016/S0301-2115(01)00474-2
    Back to article
  33. 33European Commission. “The Euromosaic study Hungarian in Romania – General information”. http://ec.europa.eu/languages/euromosaic/ro2_en.htm. Accessed 1-10-2019.
    Back to article
  34. 34Anttila A, Arbyn M, Veerus P, et al. Barriers in cervical cancer screening programs in new European Union member states. Tumori. 2010 Jul 1; 96(4): 515–6. DOI: 10.1177/030089161009600401
    Back to article
  35. 35Döbrőssy L, Kovács A and Budai A. Inequalities in cervical screening practices in Europe. Diversity & Equality in Health & Care. 2015 Jun 1; 12(2). DOI: 10.21767/2049-5471.100031
    Back to article
  36. 36Monsonego J, Hudgens MG, Zerat L, et al. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study. Int J Cancer. 2011; 129(3): 691–701. DOI: 10.1002/ijc.25726
    Back to article
  37. 37Del Mistro A, Frayle H, Ferro A, et al. Cervical cancer screening by high risk HRHPV testing in routine practice: results at one year recall of high risk HRHPV-positive and cytology-negative women. J Med Screen. 2014; 21(1): 30–7. DOI: 10.1177/0969141314522219
    Back to article
  38. 38Bigras G and de Marval F. The probability for a Pap test to be abnormal is directly proportional to HRHPV viral load: Results from a Swiss study comparing HRHPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer. 2005; 93(5): 575–81. DOI: 10.1038/sj.bjc.6602728
    Back to article
  39. 39Agarossi A, Ferrazzi E, Parazzini F, Perno CF and Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol. 2009; 81(3): 529–35. DOI: 10.1002/jmv.21347
    Back to article
  40. 40Goldman B, Rebolj M, Rygaard C, et al. Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark. Vaccine. 2013; 31(12): 1604–9. DOI: 10.1016/j.vaccine.2012.12.084
    Back to article
  41. 41World Health Organization, Reproductive Health and Chronic Diseases and Health Promotion. Comprehensive cervical cancer control: A guide to essential practice. World Health Organization. 2006; 8–11.
    Back to article
  42. 42Grigore M, Teleman SI, Pristavu A and Matei M. Awareness and knowledge about HPV and HPV vaccine among romanian women. Journal of Cancer Education. 2018 Feb 1; 33(1): 154–9. DOI: 10.1007/s13187-016-1130-2
    Back to article
DOI: https://doi.org/10.5334/aogh.2502 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Published on: Jun 20, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Minodora Bianca Ilisiu, Dana Hashim, Trude Andreassen, Nathalie C. Støer, Florian Nicula, Elisabete Weiderpass, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 85 (2019): Issue 1Next article